Benzinga | Mar 2, 2021 07:26AM EST

TherapeuticsMD Q4 EPS $(0.15) Misses $(0.10) Estimate, Sales $22.58M Beat $21.89M Estimate

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.10) by 50 percent. This is a 21.05 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $22.58 million which beat the analyst consensus estimate of $21.89 million by 3.14 percent. This is a 41.98 percent increase over sales of $15.90 million the same period last year.